Cargando…
Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
SIMPLE SUMMARY: Most breast cancers express the estrogen, progesterone, and/or HER2 receptors and patients are treated with inhibitors targeting these receptors. Triple negative breast cancers (TNBCs) lack these receptors and thus patients with TNBC do not benefit from existing targeted therapies. T...
Autores principales: | Fermaintt, Charles S., Peramuna, Thilini, Cai, Shengxin, Takahashi-Ruiz, Leila, Essif, Jacob Nathaniel, Grant, Corena V., O’Keefe, Barry R., Mooberry, Susan L., Cichewicz, Robert H., Risinger, April L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201195/ https://www.ncbi.nlm.nih.gov/pubmed/34200174 http://dx.doi.org/10.3390/cancers13112834 |
Ejemplares similares
-
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022) -
Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA
por: Fermaintt, Charles S., et al.
Publicado: (2021) -
429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2023) -
Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2019) -
Correction: Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2020)